FORTVITA Trademark

Trademark Overview


On Monday, September 30, 2024, a trademark application was filed for FORTVITA with the United States Patent and Trademark Office. The USPTO has given the FORTVITA trademark a serial number of 98778764. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, September 30, 2024. This trademark is owned by FORTVITA BIOLOGICS (SINGAPORE) PTE.LTD.. The FORTVITA trademark is filed in the Pharmaceutical Products category with the following description:

medicines for human purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; vaccines; drugs for medical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; biological preparations for medical use for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; diagnostic preparations for medical purposes; biological tissue cultures for medical purposes; chemical reagents for medical or veterinary purposes; pharmaceutical preparations, namely, ophthalmics; pharmaceutical preparations for the treatment of ophtha...
fortvita

General Information


Serial Number98778764
Word MarkFORTVITA
Filing DateMonday, September 30, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateMonday, September 30, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing0 - NOT AVAILABLE
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of the stylized word "FORTVITA" with a design element to the left featuring two overlapping abstract leaves forming a vertical stem.
Goods and Servicesmedicines for human purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; vaccines; drugs for medical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; biological preparations for medical use for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; diagnostic preparations for medical purposes; biological tissue cultures for medical purposes; chemical reagents for medical or veterinary purposes; pharmaceutical preparations, namely, ophthalmics; pharmaceutical preparations for the treatment of ophthalmic diseases and conditions; None of the aforementioned goods relating to nutritional or dietary supplements
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 30, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameFORTVITA BIOLOGICS (SINGAPORE) PTE.LTD.
Party Type10 - Original Applicant
Legal Entity Type24 - NOT AVAILABLE
AddressSINGAPORE 189767
SG

Trademark Events


Event DateEvent Description
Monday, September 30, 2024NEW APPLICATION ENTERED